BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26549250)

  • 1. A nongrading histologic approach to Clark (dysplastic) nevi: A potential to decrease the excision rate.
    Lozeau DF; Farber MJ; Lee JB
    J Am Acad Dermatol; 2016 Jan; 74(1):68-74. PubMed ID: 26549250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.
    Reddy KK; Farber MJ; Bhawan J; Geronemus RG; Rogers GS
    JAMA Dermatol; 2013 Aug; 149(8):928-34. PubMed ID: 23760581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists.
    Kolman O; Hoang MP; Piris A; Mihm MC; Duncan LM
    J Am Acad Dermatol; 2010 Oct; 63(4):661-7. PubMed ID: 20846568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.
    Kim CC; Berry EG; Marchetti MA; Swetter SM; Lim G; Grossman D; Curiel-Lewandrowski C; Chu EY; Ming ME; Zhu K; Brahmbhatt M; Balakrishnan V; Davis MJ; Wolner Z; Fleming N; Ferris LK; Nguyen J; Trofymenko O; Liu Y; Chen SC;
    JAMA Dermatol; 2018 Dec; 154(12):1401-1408. PubMed ID: 30304348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplastic nevi with severe atypia: Long-term outcomes in patients with and without re-excision.
    Engeln K; Peters K; Ho J; Jedrych J; Winger D; Ferris LK; Patton T
    J Am Acad Dermatol; 2017 Feb; 76(2):244-249. PubMed ID: 27838051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative predictive value of biopsy margins of dysplastic nevi: A single-institution retrospective review.
    Duncan JR; Purnell JC; Stratton MS; Pavlidakey PG; Huang C; Phillips CB
    J Am Acad Dermatol; 2020 Jan; 82(1):87-93. PubMed ID: 31326466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of biopsies and excisions of dysplastic acral nevi: a study of 187 lesions.
    Bronsnick T; Kazi N; Kirkorian AY; Rao BK
    Dermatol Surg; 2014 Apr; 40(4):455-9. PubMed ID: 24456372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large Acquired Nevus or Dysplastic Nevus: What's in the Name of a Nevus?
    Hofmann-Wellenhof R; Marghoob AA; Zalaudek I
    JAMA Dermatol; 2016 Jun; 152(6):623-4. PubMed ID: 26914472
    [No Abstract]   [Full Text] [Related]  

  • 11. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.
    Strazzula L; Vedak P; Hoang MP; Sober A; Tsao H; Kroshinsky D
    J Am Acad Dermatol; 2014 Dec; 71(6):1071-6. PubMed ID: 25262175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Margin comments in dermatopathology reports on dysplastic nevi influence re-excision rates.
    Comfere NI; Chakraborty R; Peters MS
    J Am Acad Dermatol; 2013 Nov; 69(5):687-692. PubMed ID: 23932648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo confocal microscopy for detection and grading of dysplastic nevi: a pilot study.
    Pellacani G; Farnetani F; Gonzalez S; Longo C; Cesinaro AM; Casari A; Beretti F; Seidenari S; Gill M
    J Am Acad Dermatol; 2012 Mar; 66(3):e109-21. PubMed ID: 21742408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplastic nevus--risk factor or disguise for melanoma.
    Dediol I; Bulat V; Zivković MV; Marković BM; Situm M
    Coll Antropol; 2011 Sep; 35 Suppl 2():311-3. PubMed ID: 22220461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
    Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
    JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border.
    Hocker TL; Alikhan A; Comfere NI; Peters MS
    J Am Acad Dermatol; 2013 Apr; 68(4):545-551. PubMed ID: 23127472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution.
    Soleymani T; Swetter SM; Hollmig ST; Aasi SZ
    J Am Acad Dermatol; 2020 Jul; 83(1):254-255. PubMed ID: 31972255
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysplastic nevus: Fact and fiction.
    Rosendahl CO; Grant-Kels JM; Que SK
    J Am Acad Dermatol; 2015 Sep; 73(3):507-12. PubMed ID: 26037217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
    Sigg C; Pelloni F; Schnyder UW
    Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.